Pharmaceutical Company Arbitrates Design Agreement, Cost Overruns

Asia - Singapore

A major pharmaceutical company arbitrated a proceeding against its design engineer for $22 million in cost overruns resulting from defects in the computer-aided design of a manufacturing facility constructed in Singapore. Our firm represented the pharmaceutical company in the arbitration, which was governed by Singapore International Arbitration rules.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.